Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.

Authors: Black, K., Shea, C., Dursun, S., Kutcher, S.
Attempt to identify the criteria for SSRI discontinuation syndrome: "These criteria are 2 or more of the following symptoms developing within 1 to 7 days of discontinuation or reduction in dosage of an SSRI after at least 1 month's use, when these symptoms cause clinically significant distress or impairment and are not due to a general medical condition or recurrence of a mental disorder: dizziness, light-headedness, vertigo or feeling faint; shock-like sensations or paresthesia; anxiety; diarrhea; fatigue; gait instability; headache; insomnia; irritability; nausea or emesis; tremor; and visual disturbances."